1. Home
  2. MEGI vs MGTX Comparison

MEGI vs MGTX Comparison

Compare MEGI & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MainStay CBRE Global Infrastructure Megatrends Term Fund

MEGI

MainStay CBRE Global Infrastructure Megatrends Term Fund

HOLD

Current Price

$15.33

Market Cap

792.7M

Sector

Finance

ML Signal

HOLD

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

HOLD

Current Price

$9.30

Market Cap

909.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEGI
MGTX
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
792.7M
909.1M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
MEGI
MGTX
Price
$15.33
$9.30
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$24.57
AVG Volume (30 Days)
147.5K
646.7K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.02
EPS
N/A
N/A
Revenue
N/A
$81,391,000.00
Revenue This Year
N/A
$141.38
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
144.57
52 Week Low
$13.42
$5.02
52 Week High
$15.89
$11.85

Technical Indicators

Market Signals
Indicator
MEGI
MGTX
Relative Strength Index (RSI) 57.07 47.17
Support Level $14.19 $7.11
Resistance Level $15.37 $9.65
Average True Range (ATR) 0.21 0.43
MACD 0.00 -0.08
Stochastic Oscillator 80.72 26.56

Price Performance

Historical Comparison
MEGI
MGTX

About MEGI MainStay CBRE Global Infrastructure Megatrends Term Fund

NYLI CBRE Global Infrastructure Megatrends Term Fund is a non-diversified, closed-end management investment company. The Fund's investment objective is to seek a high level of total return with an emphasis on current income. It is focused on the investment megatrends of decarbonization, digital transformation and asset modernization, which are reshaping the demand for infrastructure assets and driving income and growth potential.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: